Asia-Pacific

Warburg Pincus, KKR and Permira are among private equity funds included in Astrea VII – the first securitisation to offer the Singaporean public access to higher risk-return profile bonds.

Waterfield Advisors' next fund of funds could be more than five times larger than its predecessor, which has so far raised about 90% of its target, PEI has learned.

Heady fundraising could force GPs to deploy and inflate valuations. Far from being concerned, Stephen Whatmore spies a lucrative path to exit for QIC’s private capital portfolio.

VIG Fund IV is 69% invested and expected to complete one more deal this year, managing partner Chulmin Lee tells PEI.

PEI caught up with J-STAR partner Tatsuya Yumoto and IR principal Kenta Shima to discuss plans for its fifth flagship fund, which closed on $576m last week.

North American GPs accounted for 89% of Petershill Partners' invested capital as of end-December, with the remainder in Europe, according to its maiden full-year earnings.

The Japan Science and Technology Agency's university endowment will initially rely on gatekeepers until it has enough internal resources to invest directly, PE head Yasuyuki Tomita tells PEI.

AXA Hong Kong and Japan will source PE opportunities as an extension of the insurer's current primaries model, which is managed centrally from Germany.

PEI catches up with Kosmo Kalliarekos, managing director and 14-year veteran of Baring Private Equity Asia, to discuss alignment, IPOs and regulation ahead of its €6.8bn acquisition by EQT.

CBC, which made its name in Chinese healthcare, will open two international offices this year amid plans to become a 'one-stop' asset management shop, CEO Wei Fu tells PEI.